COMPANY PROFILE

Cryosa

Explore full profile

Medical device company developing novel treatments for obstructive sleep apnea

Arden Hills, United StatesFounded 2018Health Tech & Medtech

Valuation $50–100M Last recorded · 2021

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Cryosa

Cryosa, Inc. is a clinical-stage company focused on developing innovative treatments for moderate to severe Obstructive Sleep Apnea (OSA). The company operates in the medical technology sector and targets patients suffering from OSA, a condition characterized by repeated interruptions in breathing during sleep. Cryosa's proprietary technology offers a minimally invasive, incisionless solution that leverages a controlled cooling process to reduce tissue and open airways, eliminating the need for masks, hoses, or implants. The business model revolves around clinical trials, regulatory approvals, and eventual commercialization of their treatment. Revenue generation is anticipated through the sale of their medical devices and associated therapies once they receive market approval. Cryosa has successfully raised $8.25 million in Series A-2 funding to further develop their breakthrough treatment. The company is currently enrolling participants in a U.S. pilot study, ARCTIC 3, to evaluate the safety and effectiveness of their therapy.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2018
Headquarters: Arden Hills, United States
Employees: 13
Open positions: None listed
Dealroom signal: 66.3/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Surgery, Respiratory, Pulmonary, Hard Tech, DT and LS, science-based
Technology: Deep Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES B✓Equity / VC	Sep 2021	$22M	$86M	Sante Ventures · HOYA CORPORATION · Solas BioVentures	—
SERIES A✓Equity / VC	Jun 2020	$8.3M	$33M	HOYA CORPORATION · Sante Ventures	—

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Cryosa website traffic

Latest recorded traffic for Cryosa is 1.8K monthly website visits, up 0% over the last three months. Cryosa's team declined 18.8% over the past year.

Latest monthly visits1.8K 3-month web change0% 1-year team growth-18.8%

Monthly website visitsJun 2018–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
NMNoah MedicalNoah Medical's next-generation robotic platform targets early diagnosis and treatment of patients across multiple indications	Redwood City, United States	Operational	312	$150M	$600M
AMAerwave MedicalDeveloping a unique alternative to traditional medications used to treat COPD and asthma	New York City, United States	Operational
AHApreo HealthAirway scaffold implant for severe emphysema treatment	Stockholm, United States	Operational
JTJiashu Medical TechnologySpecialized medical technology for interventional pulmonology solutions	China	Operational
ESEpic Airway SystemsChanging the standard of care for elective and emergent airway management, to save lives, time and money, while reducing medication administration and improving patient and practitioner safety	Schenectady, United States	Operational
HMHollo MedicalPortable valved holding chamber for asthma inhalers	Halifax, Canada	Operational
PSPrana SurgicalInnovative solutions for early lung cancer intervention, enhancing diagnosis, reducing costs, and improving patient outcomes	Houston, United States	Operational
ARartiqMedical AI software for respiratory disease diagnostics	Seoul, South Korea	Acquired